Presentations -
-
Interaction between 5-residue Catalytide (SKGQA) and Aβ11-29
36rd Symposium on Biomedical-analytical Sciences shizuoka Japan Domestic presentation Poster presentation
2024.08Announcement date:2024.07.13
[Proceedings] 36rd Symposium on Biomedical-analytical Sciences 115 - 115 2024.08
-
Possibility of short synthetic peptides with activities of suppressing amyloid b aggregation and resolving its aggregated form as therapeutic drugs for Alzheimer's disease
The 97th Annual Meeting of the Japanease Pharmacological Society KOBE CONBENTION CENTER Domestic presentation Oral presentation (general)
2023.12Announcement date:2023.12.14
[Proceedings] 第97回日本薬理学会年会 講演要旨集 2023.12
-
Delivery of JAL-TA9 to the brain by nasal application
The 97th Annual Meeting of the Japanease Pharmacological Society KOBE CONBENTION CENTER Japan Domestic presentation Oral presentation (general)
2023.12Announcement date:2023.12.14
[Proceedings] 第97回日本薬理学会年会 講演要旨集 2023.12
-
Effects of JAL-TA9 on cognitive deficits in Alzheimer's disease model mouse
The 97th Annual Meeting of the Japanease Pharmacological Society KOBE CONBENTION CENTER Domestic presentation Oral presentation (general)
2023.12Announcement date:2023.12.14
[Proceedings] 第97回日本薬理学会年会 講演要旨集 2023.12
-
The discovery of JAL-TA9 which cleaves amyloid-β with proteolytic activity
The 97th Annual Meeting of the Japanease Pharmacological Society KOBE CONBENTION CENTER Domestic presentation Oral presentation (general)
2023.12Announcement date:2023.07.28
[Proceedings] 第97回日本薬理学会年会 講演要旨集 2023.12
-
Docking simulation of 5-Mer Peptide GSGFK and Aβ25-35
73st Kansai Regional Meeting of the Pharmaceutical Society of Japan KOBE GAKUIN Univ. Domestic presentation Poster presentation
2023.10Announcement date:2023.10.14
[Proceedings] 73st Kansai Regional Meeting of the Pharmaceutical Society of Japan 51 - 51 2023.09
-
Docking simulation of 5-Mer Peptide GSEFR and Aβ1-20
73st Kansai Regional Meeting of the Pharmaceutical Society of Japan KOBE GAKUIN Univ. Domestic presentation Poster presentation
2023.10Announcement date:2023.10.14
[Proceedings] 73st Kansai Regional Meeting of the Pharmaceutical Society of Japan 51 - 51 2023.09
-
Identification of Suppressing Aβ 25-35 Aggregation and Resolving its Aggregate Form Peptides for the Development of Drug for Alzhemer's Disease
35rd Symposium on Biomedical-analytical Sciences HOKKAIDO Unv. Japan Domestic presentation Oral presentation (general)
2023.07Announcement date:2023.07.28
[Proceedings] 35rd Symposium on Biomedical-analytical Sciences 47 - 47 2023.07
-
LYZ-A3, the 8-mer fragment peptide derived from Lysozyme, ameliorates α-Syn61-84 peptide-induced short memory impairment and motor dysfunction by suppressing aggregation of α-Syn61-84 peptide
18th Annual Congress of International Drug Discovery Science & Technology Amsterdam Netherlands International presentation Oral presentation (general)
2023.07Announcement date:2023.07.13
-
Five-mer peptides GSGFK and GSGNR suppress and resolve the aggregation of Aβ25-35.
Annual Congress of International Drug Discovery Science & Technology Amsterdam Netherlands International presentation Oral presentation (general)
2023.07Announcement date:2023.07.13
-
Structural analysis of the peptide GSGFK that inhibits amyloid β25-35 aggregation
The 143rd Annual Meeting of the Pharmaceutical Society of Japan Sapporo (Hokkaido Univ.) Domestic presentation Poster presentation
2023.03[Proceedings] 日本薬学会第143年会 2023.03
-
Structural analysis of peptides (GSGNR,GSGHR) that inhibit amyloid-β aggregation
72st Kansai Regional Meeting of the Pharmaceutical Society of Japan 大阪 Domestic presentation Poster presentation
2022.10[Proceedings] 72st Kansai Regional Meeting of the Pharmaceutical Society of Japan 2022.10
-
Docking simulation of 5-Mer Catalytide (GSGFK) and α-Synuclein 61-84
72st Kansai Regional Meeting of the Pharmaceutical Society of Japan 大阪 Domestic presentation Poster presentation
2022.10[Proceedings] 72st Kansai Regional Meeting of the Pharmaceutical Society of Japan 2022.10
-
Identification of the seeds peptides for the drug of Parkinson's disease
34rd Symposium on Biomedical-analytical Sciences Chiba Domestic presentation Oral presentation (general)
2022.09[Proceedings] 34rd Symposium on Biomedical-analytical Sciences 48 - 48 2022.09
-
Docking simulation of 5-Mer Catalytide (GSGNR) and Aβ25-35
71st Kansai Regional Meeting of the Pharmaceutical Society of Japan 大阪 Domestic presentation Poster presentation
2021.10[Proceedings] 71st Kansai Regional Meeting of the Pharmaceutical Society of Japan
-
JAL-TA9 improves cognitive dysfunction of AD by cleavage reaction against Amyloidβ
33rd Symposium on Biomedical-analytical Sciences Kyoto Domestic presentation Poster presentation
2021.09[Proceedings] 33rd Symposium on Biomedical-analytical Sciences 2021.09
-
Identification of candidate peptide drugs for Parkinson's disease using peptide induced model mouse
33rd Symposium on Biomedical-analytical Sciences Kyoto Domestic presentation Poster presentation
2021.09[Proceedings] 33rd Symposium on Biomedical-analytical Sciences 2021.09
-
Interaction between 5-Mer Catalytide (GSGHR) and Aβ14-23
33rd Symposium on Biomedical-analytical Sciences Kyoto, Domestic presentation Poster presentation
2021.09[Proceedings] 33rd Symposium on Biomedical-analytical Sciences 88 - 88 2021.09
-
Nasal Application of the 9-mer hydrolase-peptide, JAL-TA9 improved Dementia of Alzheimer’s model mouse induced by Aβ25-35
31st International Symposium on Pharmaceutical and Biomedical Analysis Kyoto,Japan International presentation Symposium, workshop panel (public)
2021.08-2021.09[Proceedings] 31st International Symposium on Pharmaceutical and Biomedical Analysis 74 - 74 2021.08
-
Simulation of Binding Structure of GSGNR Inhibiting Aβ25-35 Aggregation
31st International Symposium on Pharmaceutical and Biomedical Analysis Kyoto,Japan International presentation Symposium, workshop panel (public)
2021.08-2021.09[Proceedings] 31st International Symposium on Pharmaceutical and Biomedical Analysis 75 - 75 2021.08